CX614

CAS No. 191744-13-5

CX614( CX 614 | CX-614 )

Catalog No. M27131 CAS No. 191744-13-5

CX614 is a positive allosteric modulator of the AMPA receptor concerning AMPA.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CX614
  • Note
    Research use only, not for human use.
  • Brief Description
    CX614 is a positive allosteric modulator of the AMPA receptor concerning AMPA.
  • Description
    CX614 is a positive allosteric modulator of the AMPA receptor concerning AMPA.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CX 614 | CX-614
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    β-adrenergic receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    191744-13-5
  • Formula Weight
    247.25
  • Molecular Formula
    C13H13NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1N2CCCC2Oc2cc3OCCOc3cc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.K Araki, et al. Pharmacological studies on supersensitization. VII. Inhibitory effect of dibenamine on cocaine-induced supersensitivity of isolated vas deferens of guinea pig. J Pharmacobiodyn. 1982 Oct;5(10):789-95.
molnova catalog
related products
  • Memantine hydrochlor...

    Memantine is an uncompetitive NMDA receptor antagonist. When using HEK293 cells express recombinant rat NMDA receptors, memantine shows inhibition of L-glutamate-mediated response with a dose- and voltage-dependent manner.

  • SBC-110736

    SBC-110736 is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor.

  • LY-2300559

    LY-2300559 is an agonist of metabotropic glutamate receptor 2 (mGluR2) and can be used in studies about the treatment of migraine.